In addition, increasing evidence reveals that RACGAP1 contributes to tumorigenesis and malignant progression of several malignancies, such as hepatocellular carcinoma 6, bladder cancer 7, gastric cancer 8, and breast cancer 9. This evidence concerns the gene RACGAP1 and breast carcinoma.